Metastatic Malignant Neoplasm
Oncology
3
Pipeline Programs
2
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
2
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
TempusIL - Chicago
1 program1
Targeted Therapy Based on Molecular ProfilingPhase 21 trial
Active Trials
NextPoint TherapeuticsMA - Cambridge
2 programs2
NPX267Phase 11 trial
NPX887Phase 11 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
TempusTargeted Therapy Based on Molecular Profiling
NextPoint TherapeuticsNPX887
NextPoint TherapeuticsNPX267
Clinical Trials (3)
Total enrollment: 275 patients across 3 trials
Initiative for Molecular Profiling and Advanced Cancer Therapy (IMPACT II)
Start: May 2014Est. completion: Dec 2030
Phase 2Active Not Recruiting
A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
Start: Jan 2024Est. completion: Aug 2027144 patients
Phase 1Recruiting
A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7
Start: Jul 2023Est. completion: Sep 2025131 patients
Phase 1Suspended
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
1h ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
1h ago
Office Administrator
SystImmune
1h ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
1h ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
1h ago
Working Student Active Sourcing Support (m/f/d)
Mindpeak
Hamburg
1h ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 275 patients
2 companies competing in this space